title: Oxidant-induced inhibition of myocardial calcium-independent phospholipase A2.
abstract: We discovered the acute inhibition of myocardial phospholipase A2 activity by micromolar concentrations of tert-butyl hydroperoxide and hydrogen peroxide. Specifically, freshly isolated adult rat cardiomyocytes were treated with the oxidants for 30 min, and phospholipase A2 activity was assessed in cell subcellular fractions using (16:0, [3H]18:1) plasmenylcholine and phosphatidylcholine substrates in the absence or presence of calcium. Calcium-independent phospholipase A2 activity was inhibited by approx 50% in both the cytosolic and membrane fractions by the oxidants. The inhibition of the phospholipase A2 activity was concentration dependent and preceded detectable changes in cell viability as assessed by lactate dehydrogenase release and rod-shaped morphology. Taking into account that oxidized sn-2 fatty acyl groups must first be hydrolyzed by phospholipase A2 to be repaired by glutathione peroxidase, we suggest that the observed inhibition of phospholipase A2 activity by oxidants compromises the myocyte's ability to deal with lipid peroxidation. This conclusion was further validated by the experiments in which pretreatment with the calcium-independent phospholipase A2 inhibitor bromoenol lactone exacerbated cardiotoxicity of tert-butyl hydroperoxide in myocyte cultures.
authors.affiliation: Department of Pathology, Saint Louis University School of Medicine, St. Louis, MO 63104, USA.
authors.forename: J
authors.initials: J
authors.lastname: McHowat
authors.forename: L M
authors.initials: LM
authors.lastname: Swift
authors.forename: N
authors.initials: N
authors.lastname: Sarvazyan
mesh_terms: D000818:Animals; D002462:Cell Membrane / Q000201:enzymology; D003600:Cytosol / Q000201:enzymology; D004357:Drug Synergism; D054522:Group VI Phospholipases A2; D006861:Hydrogen Peroxide / Q000378:metabolism / Q000494:pharmacology; D009206:Myocardium / Q000201:enzymology* / Q000473:pathology; D009281:Naphthalenes / Q000633:toxicity; D016877:Oxidants / Q000633:toxicity*; D018384:Oxidative Stress / Q000187:drug effects; D010741:Phospholipases A / Q000037:antagonists & inhibitors*; D054467:Phospholipases A2; D011753:Pyrones / Q000633:toxicity; D051381:Rats; D017207:Rats, Sprague-Dawley; D020122:tert-Butylhydroperoxide / Q000378:metabolism / Q000494:pharmacology
chemical_list: D009281:Naphthalenes; D016877:Oxidants; D011753:Pyrones; C068314:6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-one; D020122:tert-Butylhydroperoxide; D006861:Hydrogen Peroxide; D010741:Phospholipases A; D054522:Group VI Phospholipases A2; D054467:Phospholipases A2